Clinical uses of nalidixic acid analogues: the fluoroquinolones.

European journal of clinical microbiology ·Vol. 5 ·No. 2 ·1986-04-00 ·Pages 138-40

Høiby N

Abstract

暂无摘要

MeSH Terms

Administration, Oral Anti-Infective Agents/metabolism,therapeutic use Bacterial Infections/drug therapy Ciprofloxacin Drug Evaluation Drug Resistance, Microbial Enoxacin Fluoroquinolones Humans Male Nalidixic Acid/analogs & derivatives Naphthyridines/metabolism,therapeutic use Norfloxacin/analogs & derivatives,metabolism,therapeutic use Ofloxacin Oxazines/metabolism,therapeutic use Pefloxacin Quinolines/metabolism,therapeutic use Topoisomerase II Inhibitors

Chemicals

Anti-Infective Agents Fluoroquinolones Naphthyridines Oxazines Quinolines Topoisomerase II Inhibitors Pefloxacin Enoxacin Nalidixic Acid Ciprofloxacin amifloxacin Ofloxacin Norfloxacin

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Høiby N

References (28)

28 references, click to expand

Ciprofloxacin-resistant Pseudomonas.
Lancet. 1985 Jun 22;1(8443):1442 PMID: 2861375
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Antimicrob Agents Chemother. 1984 Jun;25(6):775-7 PMID: 6234858
Investigations into the mechanism of action of the antibacterial agent norfloxacin.
J Antimicrob Chemother. 1984 May;13 Suppl B:9-23 PMID: 6203890
Use of enoxacin in a patient with cystic fibrosis.
Lancet. 1985 Mar 16;1(8429):646 PMID: 2857989
A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:91-4 PMID: 6438048
Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.
N Engl J Med. 1984 Jul 19;311(3):137-40 PMID: 6234465
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Antimicrob Agents Chemother. 1984 Oct;26(4):481-4 PMID: 6240223
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
J Infect Dis. 1985 Jul;152(1):104-7 PMID: 3159811
Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
J Antimicrob Chemother. 1984 May;13 Suppl B:79-83 PMID: 6234279
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
Antimicrob Agents Chemother. 1985 Mar;27(3):297-301 PMID: 3158272
Elimination of plasmids by new 4-quinolones.
Antimicrob Agents Chemother. 1985 Nov;28(5):700-2 PMID: 3911881
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
Antimicrob Agents Chemother. 1985 Nov;28(5):716-21 PMID: 2936302
Enoxacin for the treatment of urinary tract infection.
N Z Med J. 1985 Apr 24;98(777):286-8 PMID: 3857511
Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.
Antimicrob Agents Chemother. 1985 Nov;28(5):663-6 PMID: 2936301
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Antimicrob Agents Chemother. 1985 Aug;28(2):331-42 PMID: 2939797
Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
Drugs Exp Clin Res. 1985;11(5):351-6 PMID: 2941264
Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.
J Antimicrob Chemother. 1984 May;13 Suppl B:99-105 PMID: 6234282
Clinical resistance to long-term oral ciprofloxacin.
Lancet. 1985 Jun 1;1(8440):1275 PMID: 2860471
Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1986 Jan;29(1):1-6 PMID: 3015000
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
Antimicrob Agents Chemother. 1985 Mar;27(3):422-3 PMID: 3158277
Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
J Antimicrob Chemother. 1985 Nov;16(5):581-7 PMID: 3935637
In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.
J Antimicrob Chemother. 1985 Dec;16(6):713-7 PMID: 2936706
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
J Antimicrob Chemother. 1984 May;13 Suppl B:89-94 PMID: 6234281
The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin.
J Antimicrob Chemother. 1984 May;13 Suppl B:85-8 PMID: 6234280
Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria.
Antimicrob Agents Chemother. 1985 Aug;28(2):308-10 PMID: 2939795
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
J Infect Dis. 1985 Feb;151(2):291-4 PMID: 3155780
Mutational resistance to 4-quinolone antibacterial agents.
Eur J Clin Microbiol. 1984 Aug;3(4):347-50 PMID: 6237904

Article Info

Journal

European journal of clinical microbiology

Abbr.

Eur J Clin Microbiol

ISSN

0722-2211

DOI

10.1007/BF02013968

Published

1986-04-00

Pages

138-40

Language

English

Region

Germany

NLM ID

8219582

Subset

External Links

PubMed source DOI: 10.1007/BF02013968

Analysis Services

Clinical uses of nalidixic acid analogues: the fluoroquinolones.

Contact

WeChat Official Account